An E115A Missense Variant in CERS2 Is Associated With Increased Sleeping Energy Expenditure and Hepatic Insulin Resistance in American Indians

Overview

Journal Diabetes

Specialty Endocrinology

Date 2024 May 22

PMID 38776413

Authors

Sascha Heinitz

Michael Traurig

Jonathan Krakoff

Philipp Rabe

Claudia Staubert

Sayuko Kobes

Robert L Hanson

Michael Stumvoll

Matthias Bluher

Clifton Bogardus

Leslie Baier

Paolo Piaggi

Affiliations

Soon will be listed here.

Abstract

Article Highlights:

Citing Articles

Reduced circulating sphingolipids and activity are linked to T2D risk and impaired insulin secretion.

Khan S, Ye W, Van J, Singh I, Rabiee Y, Rodricks K Sci Adv. 2025; 11(2):eadr1725.

PMID: 39792658 PMC: 11790001. DOI: 10.1126/sciadv.adr1725.

References

Ravussin E, Lillioja S, Knowler W, Christin L, Freymond D, Abbott W . Reduced rate of energy expenditure as a risk factor for body-weight gain. N Engl J Med. 1988; 318(8):467-72. DOI: 10.1056/NEJM198802253180802. View

Summers S . Could Ceramides Become the New Cholesterol?. Cell Metab. 2018; 27(2):276-280. DOI: 10.1016/j.cmet.2017.12.003. View

Lillioja S, Mott D, Zawadzki J, Young A, Abbott W, Bogardus C . Glucose storage is a major determinant of in vivo "insulin resistance" in subjects with normal glucose tolerance. J Clin Endocrinol Metab. 1986; 62(5):922-7. DOI: 10.1210/jcem-62-5-922. View

Raichur S, Wang S, Chan P, Li Y, Ching J, Chaurasia B . CerS2 haploinsufficiency inhibits β-oxidation and confers susceptibility to diet-induced steatohepatitis and insulin resistance. Cell Metab. 2014; 20(4):687-95. DOI: 10.1016/j.cmet.2014.09.015. View

Turpin-Nolan S, Bruning J . The role of ceramides in metabolic disorders: when size and localization matters. Nat Rev Endocrinol. 2020; 16(4):224-233. DOI: 10.1038/s41574-020-0320-5. View

Howie B, Donnelly P, Marchini J . A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet. 2009; 5(6):e1000529. PMC: 2689936. DOI: 10.1371/journal.pgen.1000529. View

Nicholson R, Poss A, Maschek J, Cox J, Hopkins P, Hunt S . Characterizing a Common CERS2 Polymorphism in a Mouse Model of Metabolic Disease and in Subjects from the Utah CAD Study. J Clin Endocrinol Metab. 2021; 106(8):e3098-e3109. PMC: 8277214. DOI: 10.1210/clinem/dgab155. View

Lillioja S, Mott D, Zawadzki J, Young A, Abbott W, Knowler W . In vivo insulin action is familial characteristic in nondiabetic Pima Indians. Diabetes. 1987; 36(11):1329-35. DOI: 10.2337/diab.36.11.1329. View

Rector R, Morris E, Ridenhour S, Meers G, Hsu F, Turk J . Selective hepatic insulin resistance in a murine model heterozygous for a mitochondrial trifunctional protein defect. Hepatology. 2013; 57(6):2213-23. PMC: 3660447. DOI: 10.1002/hep.26285. View

10.

Backe P, Laerdahl J, Kittelsen L, Dalhus B, Morkrid L, Bjoras M . Structural basis for substrate and product recognition in human phosphoglucomutase-1 (PGM1) isoform 2, a member of the α-D-phosphohexomutase superfamily. Sci Rep. 2020; 10(1):5656. PMC: 7101342. DOI: 10.1038/s41598-020-62548-0. View

11.

Quehenberger O, Armando A, Brown A, Milne S, Myers D, Merrill A . Lipidomics reveals a remarkable diversity of lipids in human plasma. J Lipid Res. 2010; 51(11):3299-305. PMC: 2952570. DOI: 10.1194/jlr.M009449. View

12.

Weyer C, Bogardus C, Pratley R . Metabolic factors contributing to increased resting metabolic rate and decreased insulin-induced thermogenesis during the development of type 2 diabetes. Diabetes. 1999; 48(8):1607-14. DOI: 10.2337/diabetes.48.8.1607. View

13.

Sokolowska E, Blachnio-Zabielska A . The Role of Ceramides in Insulin Resistance. Front Endocrinol (Lausanne). 2019; 10:577. PMC: 6712072. DOI: 10.3389/fendo.2019.00577. View

14.

Park J, Park W, Kuperman Y, Boura-Halfon S, Pewzner-Jung Y, Futerman A . Ablation of very long acyl chain sphingolipids causes hepatic insulin resistance in mice due to altered detergent-resistant membranes. Hepatology. 2012; 57(2):525-32. DOI: 10.1002/hep.26015. View

15.

Schutz Y, Ravussin E, DIETHELM R, Jequier E . Spontaneous physical activity measured by radar in obese and control subject studied in a respiration chamber. Int J Obes. 1982; 6(1):23-8. View

16.

Bickert A, Kern P, van Uelft M, Herresthal S, Ulas T, Gutbrod K . Inactivation of ceramide synthase 2 catalytic activity in mice affects transcription of genes involved in lipid metabolism and cell division. Biochim Biophys Acta Mol Cell Biol Lipids. 2018; 1863(7):734-749. DOI: 10.1016/j.bbalip.2018.04.006. View

17.

Sociale M, Wulf A, Breiden B, Klee K, Thielisch M, Eckardt F . Ceramide Synthase Schlank Is a Transcriptional Regulator Adapting Gene Expression to Energy Requirements. Cell Rep. 2018; 22(4):967-978. DOI: 10.1016/j.celrep.2017.12.090. View

18.

Tataranni P, Ravussin E . Use of dual-energy X-ray absorptiometry in obese individuals. Am J Clin Nutr. 1995; 62(4):730-4. DOI: 10.1093/ajcn/62.4.730. View

19.

Bandesh K, Traurig M, Chen P, Hsueh W, Hanson R, Piaggi P . Identification and characterization of the long non-coding RNA NFIA-AS2 as a novel locus for body mass index in American Indians. Int J Obes (Lond). 2023; 47(6):434-442. PMC: 10212757. DOI: 10.1038/s41366-023-01278-5. View

20.

Ravussin E, Lillioja S, Anderson T, Christin L, Bogardus C . Determinants of 24-hour energy expenditure in man. Methods and results using a respiratory chamber. J Clin Invest. 1986; 78(6):1568-78. PMC: 423919. DOI: 10.1172/JCI112749. View